MedTrace Logo

Effect of Feeding Jejunostomy on Sarcopenia in Patients With Esophageal Cancer

NCT06712706 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-04-23

No results posted yet for this study

Summary

Participants were diagnosed with esophageal cancer needing chemo- or radiochemotherapy before the potentially curing surgery consisting of esophagectomy. At the time of diagnosis, in all participants, a laparoscopy to complete staging was performed. In some patients, a feeding jejunostomy tube (FJT) was placed at the time of staging laparoscopy; in others, the FJT was placed at the time of esophagectomy. A common risk factor for higher morbidity and mortality is sarcopenia, a condition associated with low skeletal muscle. This study aims to determine whether the timing of the FJT placement affects the progress of sarcopenia.

Conditions

  • Esophageal Cancer
  • Esophageal Carcinoma
  • Sarcopenia
  • Feeding Tube

Interventions

PROCEDURE

Feeding jejunostomy placement

Placement of feeding jejunostomy at staging laparoscopy

PROCEDURE

Feeding jejunostomy placement at esophagectomy

Placement of feeding jejunostomy at esophagectomy

Sponsors & Collaborators

  • Stefan Gutknecht

    lead OTHER

Principal Investigators

  • Stefan Gutknecht, Dr. med. · Stadtspital Zürich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2025-01-31
Completion
2026-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06712706 on ClinicalTrials.gov